William G. Richards is Head of Therapeutics Discovery at 23andMe Holding Co. (ME). They have made 1 open-market trade across 1 company since 2023, most recently 2024-08-20.
CIK 0001988459
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ME | 573,069 | $347K |
Shares reported on the most recent Form 4, priced at the 2024-08-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ME | SELL | 2023-09-05 | 2023-09-06 | $1.08 | $3K | -6.4% | -21.2% | -12.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.